Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Colonic Neoplasms 3Adenoma 2Venous Thromboembolism 1Urinary Bladder Neoplasms 1Thrombocytopenia 1Soft Tissue Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Node Positive HER2 Negative Breast Cancer 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Myocardial Infarction 1Multiple Myeloma 1Hereditary Sensory and Autonomic Neuropathies 1Hematuria 1Hematologic Diseases 1Glioblastoma 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Adenomatous Polyps 1Adenocarcinoma of Lung 1Acute Coronary Syndrome 1

Interventions

Gemcitabine 25Cisplatin 19pembrolizumab 11avelumab 10Nivolumab 7Mitomycin 6Carboplatin 6apaziquone 5Paclitaxel 5Vinblastine 4Methotrexate 4Doxorubicin 4Docetaxel 4BCG Vaccine 4vofatamab 3durvalumab 3atezolizumab 3Sunitinib 3Standard of Care 3Sorafenib 3Radiotherapy, Intensity-Modulated 3Radiotherapy 3Radiation 3Magnetic Resonance Spectroscopy 3Lapatinib 3Cystectomy 3B701 protein, Human herpesvirus 6 3valrubicin 2rucaparib 2enfortumab vedotin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Urinary Bladder Neoplasms × Aspirin × Clear all
NCT02350543 2019-04-08

Peri-operative Aspirin Continuation Versus Discontinuation

Rabin Medical Center

Phase 4 Terminated
50 enrolled
Genitourinary

Urinary Bladder Neoplasms, Hematuria

Data powered by HemOnc (CC BY 4.0) Colophon âš¡